Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
March 19, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study
Rena Buckstein, Richard A Wells, Nancy Zhu, et al.
Leukemia
|
December 19, 2023
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
Tracy Murphy, Jacqueline M Mason, Brian Leber, et al.
British Journal of Haematology
|
June 1, 2021
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study
Irina Amitai, Michelle Geddes, Nancy Zhu, et al.
British Journal of Haematology
|
July 6, 2017
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysis
Heather A Leitch, Ambica Parmar, Richard A Wells, et al.
Cell
|
May 29, 2012
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells
Eleftherios Sachlos, Ruth M Risueño, Sarah Laronde, et al.
Haematologica
|
August 18, 2022
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
Jennifer Teichman, Michelle Geddes, Nancy Zhu, et al.
Haematologica
|
July 10, 2025
Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia
Tracy Murphy, Boyang Zhang, Tong Zhang, et al.
American Journal of Hematology
|
February 12, 2024
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, et al.
Leukemia & Lymphoma
|
November 9, 2024
Improvement in quality of life in MDS patients who become transfusion independent after treatment
Bo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.
Leukemia
|
August 29, 2020
Revised 15-item MDS-specific frailty scale maintains prognostic potential
Bo A Wan, Aziz Nazha, Rebecca Starkman, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
March 19, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study
Rena Buckstein, Richard A Wells, Nancy Zhu, et al.
Leukemia
|
December 19, 2023
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
Tracy Murphy, Jacqueline M Mason, Brian Leber, et al.
British Journal of Haematology
|
June 1, 2021
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study
Irina Amitai, Michelle Geddes, Nancy Zhu, et al.
British Journal of Haematology
|
July 6, 2017
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysis
Heather A Leitch, Ambica Parmar, Richard A Wells, et al.
Cell
|
May 29, 2012
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells
Eleftherios Sachlos, Ruth M Risueño, Sarah Laronde, et al.
Haematologica
|
August 18, 2022
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
Jennifer Teichman, Michelle Geddes, Nancy Zhu, et al.
Haematologica
|
July 10, 2025
Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia
Tracy Murphy, Boyang Zhang, Tong Zhang, et al.
American Journal of Hematology
|
February 12, 2024
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, et al.
Leukemia & Lymphoma
|
November 9, 2024
Improvement in quality of life in MDS patients who become transfusion independent after treatment
Bo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.
Leukemia
|
August 29, 2020
Revised 15-item MDS-specific frailty scale maintains prognostic potential
Bo A Wan, Aziz Nazha, Rebecca Starkman, et al.
Page
of 13